US2012252050A1PendingUtilityA1

Methods for assessing risk of bone fracture

41
Assignee: TOWLER MARK ROBERTPriority: Jun 22, 2004Filed: Nov 22, 2011Published: Oct 4, 2012
Est. expiryJun 22, 2024(expired)· nominal 20-yr term from priority
G01N 21/65A61B 5/0075A61B 5/4509G01N 33/68G01R 33/465G01N 2030/8831A61B 5/7275A61B 5/4869G01N 2333/4742A61B 5/6826A61B 5/4504
41
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention generally relates to methods for assessing risk of bone fracture. In certain embodiments, methods of the invention involve a) conducting an assay to determine a characteristic of keratinized tissue obtained from a mammal, b) analyzing at least one bone-fracture risk factor associated with the mammal, and c) correlating results from steps (a) and (b), thereby assessing the risk of bone fracture of a bone of the mammal.

Claims

exact text as granted — not AI-modified
1 . A method for assessing risk of bone fracture of a bone of a mammal, the method comprising:
 a) conducting an assay to determine a characteristic of keratinized tissue obtained from a mammal;   b) analyzing at least one bone-fracture risk factor associated with the mammal; and   c) correlating results from steps (a) and (b), thereby assessing the risk of bone fracture of a bone of the mammal.   
     
     
         2 . The method according to  claim 1 , wherein the assay is performed in situ. 
     
     
         3 . The method according to  claim 1 , wherein assay is measuring chemical changes in the tissue. 
     
     
         4 . The method according to  claim 3 , wherein the chemical changes in the tissue are changes in levels of sulfur bonding. 
     
     
         5 . The method according to  claim 1 , wherein the assay is performed by a technique selected from the group consisting of: Raman spectroscopy; nuclear magnetic resonance spectroscopy; infrared spectroscopy; chiroptical techniques; mass spectrometry; chromatography; and reactions with Elman's reagent. 
     
     
         6 - 7 . (canceled) 
     
     
         8 . The method according to  claim 1 , wherein the assay comprises measuring changes in chemical composition of the tissue by a Raman spectroscopy technique. 
     
     
         9 . The method according to  claim 8 , wherein the measurement is obtained at a depth of least 50 microns into the tissue. 
     
     
         10 . The method according to  claim 8 , further comprising performing a spectral analysis of obtained Raman spectra by multivariate analysis. 
     
     
         11 . The method according to  claim 8 , wherein changes in chemical composition of the tissue are changes in levels of sulfur bonding in proteins in the tissue. 
     
     
         12 . The method according to  claim 8 , wherein the Raman spectroscopy measures a peak or set of peaks in a 0-4000 cm −1  spectral region. 
     
     
         13 . The method according to  claim 8 , wherein the Raman spectroscopy measures a peak selected from the group consisting of: a peak at about 510 cm −1 ; a peak at about 621 cm −1 ; and a peak at about 643 cm −1 . 
     
     
         14 . The method according to  claim 1 , wherein the keratinized tissue is selected from the group consisting of: nail; hair; and skin. 
     
     
         15 . The method according to  claim 14 , wherein the nail is a clipped finger nail or toe nail. 
     
     
         16 . The method according to  claim 15 , wherein the clipped finger nail or toe nail has been archived for a period of time. 
     
     
         17 . The method according to  claim 1 , wherein the bone is a hip bone. 
     
     
         18 . The method according to  claim 1 , wherein the bone-fracture risk factor is selected from the group consisting of: age, body mass index (BMI), smoking status, thyroid hormone use, diet, age at menopause, alcohol consumption, diagnosis of osteoporosis, and a combination thereof. 
     
     
         19 . The method according to  claim 1 , wherein prior to the conducting step, the method further comprises obtaining the keratinized tissue from the mammal. 
     
     
         20 . The method according to  claim 1 , wherein the mammal is a human female. 
     
     
         21 . The method according to  claim 20 , wherein the female is post-menopausal. 
     
     
         22 . The method according to  claim 21 , wherein the female is younger than 65 years of age. 
     
     
         23 . A method for assessing risk of bone fracture of a bone of a mammal, the method comprising:
 measuring changes in chemical composition of keratinized tissue by a Raman spectroscopy technique; and   comparing obtained Raman spectra to a set of reference spectra, thereby assessing the risk of bone fracture of a bone of the mammal.   
     
     
         24 . The method according to  claim 23 , wherein the measurement is obtained at a depth of least 50 microns into the tissue. 
     
     
         25 . The method according to  claim 23 , wherein changes in chemical composition of the tissue are changes in levels of sulfur bonding in proteins in the tissue. 
     
     
         26 . The method according to  claim 23 , wherein the Raman spectroscopy measures a peak or set of peaks in a 0-4000 cm −1  spectral region. 
     
     
         27 . The method according to  claim 23 , wherein the Raman spectroscopy measures a peak selected from the group consisting of: a peak at about 510 cm −1 ; a peak at about 621 cm −1 ; and a peak at about 643 cm −1 . 
     
     
         28 . The method according to  claim 23 , wherein the keratinized tissue is selected from the group consisting of: nail; hair; and skin. 
     
     
         29 . The method according to  claim 28 , wherein the nail is a clipped finger nail or toe nail. 
     
     
         30 . The method according to  claim 29 , wherein the clipped finger nail or toe nail has been archived for a period of time. 
     
     
         31 . The method according to  claim 23 , wherein the bone is a hip bone. 
     
     
         32 . The method according to  claim 23 , wherein prior to the measuring step, the method further comprises obtaining the keratinized tissue from the mammal. 
     
     
         33 . The method according to  claim 23 , wherein the mammal is a human female. 
     
     
         34 . The method according to  claim 33 , wherein the female is post-menopausal. 
     
     
         35 . The method according to  claim 34 , wherein the female is younger than 65 years of age. 
     
     
         36 . The method according to  claim 23 , wherein prior to the performing step, the method further comprises performing a spectral analysis of obtained Raman spectra by multivariate analysis. 
     
     
         37 . The method according to  claim 23 , further comprising a spectral analysis of obtained Raman spectra by multivariate analysis.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.